Editorial Board
Alessandra Granata
University of Cambridge · United Kingdom
Editorial leadership for International Journal of Vasculitis
Research interests
- Cardiovascular Disease
- Cerebral Small Vessel Disease
- Stroke
- Stem Cell Biology
- Induced Pluripotent Stem Cells
Biography
- I am Stem Cell Scientist leading the research group for modeling cerebrovascular diseases using patient-derived induced pluripotent stem cells (iPSC).
- I obtained my PhD in Cell and Developmental Biology at King's College London and completed two postdoctoral research fellowships in the department of Clinical Neurosciences at UCL and in the department of Medicine, Cardiovascular Division, at the University of Cambridge.
- Currently I am working on a project to develop human iPSC-based models to investigate the mechanisms underlying genetic Cerebral Small Vessel Diseases.
- I believe that iPSC model offer a powerful screening platform for new target/drug discovery and personalised medicine, ultimately, resulting in improved patient care.
Selected publications
- A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases 2023 cited 26×
- Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants 2023 cited 12×
- In vitro platform to model the function of ionocytes in the human airway epithelium 2024 cited 10×
- A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases in extracellular matrix abnormalities 2023 cited 1×
- An iPSC-derived model for drug screening in cerebral small vessel disease Recent 2025
- A phenotypic screen of Marfan syndrome iPSC-derived vascular smooth muscle cells uncovers GSK3β as a new target 2022
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJV for your work?
This journal is guided by Alessandra Granata (University of Cambridge) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.